
Vorgun M 500mg/0.2mg Tablet SR
Marketer
Daxia Healthcare
Salt Composition
Metformin (500mg) + Voglibose (0.2mg)
Overview Vorgun M 500mg/0.2mg Tablet SR
Diabetics using Vorgun M 500mg/0.2mg SR tablets, an antidiabetic combination medication, should adhere to their physician's prescribed dosage and timing. This medication, for adult type 2 diabetes management, effectively regulates blood glucose. Consistent daily intake, ideally with meals, maximizes efficacy. Dosage adjustments are common, depending on blood sugar monitoring results. Discontinuing Vorgun M without medical consultation risks elevated blood sugar, potentially leading to complications like kidney disease, vision impairment, neuropathy, and limb loss. A comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor, is crucial. While side effects such as nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes are possible, they're often transient. Persistent or concerning side effects require medical attention. Vorgun M is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease, pregnancy, or breastfeeding should consult their physician before initiating treatment. Regular blood sugar checks, along with potential blood tests to monitor blood cell counts and liver function, are recommended.
Uses of Vorgun M 500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vorgun M 500mg/0.2mg Tablet SR:
Your physician will determine the correct dosage and treatment length for this medication. Ingest the Vorgun M 500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or breaking it. Take with food.
Common Side effects of Vorgun M 500mg/0.2mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Vorgun M 500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vorgun M 500mg/0.2mg Extended-Release tablets with food.
How Vorgun M 500mg/0.2mg Tablet SR works:
Sustained-release Vorgun M tablets (500mg/0.2mg) contain a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Vorgun M 500mg/0.2mg Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Vorgun M 500mg/0.2mg Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against the risks prior to prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vorgun M 500mg/0.2mg tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vorgun M 500mg/0.2mg Tablet SR. Nevertheless, concurrent use with other antidiabetic medications, including sulfonylureas, insulin, and repaglinide, carries a risk of low blood sugar that patients should be aware of.
KidneyCAUTION
Patients with kidney impairment should use Vorgun M 500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is recommended during treatment. Consult your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Vorgun M 500mg/0.2mg Tablet SR to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Vorgun M 500mg/0.2mg Tablet SR :
Should you forget to take your Vorgun M 500mg/0.2mg Tablet SR, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Vorgun M 500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
